This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Astrazeneca Ab, Ionis Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,534 
1 out of 289 
Years Active: 2024
Title: William John Drury, III: Innovator in GLP-1 Receptor Ligands
Introduction
William John Drury, III is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target specific receptors in the body. His work has implications for various therapeutic applications.
Latest Patents
Drury holds a patent for "GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof." This patent describes compounds and methods for targeting cells that express the GLP-1 receptor. The innovation aims to enhance the effectiveness of treatments related to metabolic disorders.
Career Highlights
Throughout his career, Drury has worked with prominent companies in the pharmaceutical industry. He has been associated with AstraZeneca AB and Ionis Pharmaceuticals, Inc., where he has contributed to groundbreaking research and development efforts.
Collaborations
Drury has collaborated with esteemed colleagues, including Brett P. Monia and Thazha P. Prakash. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.
Conclusion
William John Drury, III is a distinguished inventor whose work in GLP-1 receptor ligands has the potential to impact therapeutic strategies significantly. His contributions to the field exemplify the importance of innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile